Bioceres Crop Solutions Corp. (BIOX)
NASDAQ: BIOX · Real-Time Price · USD
4.550
-0.190 (-4.01%)
Feb 21, 2025, 4:00 PM EST - Market closed
Bioceres Crop Solutions Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Revenue | 407.77 | 464.83 | 419.45 | 328.46 | 206.7 | 172.35 | Upgrade
|
| Revenue Growth (YoY) | -10.29% | 10.82% | 27.70% | 58.91% | 19.93% | 7.51% | Upgrade
|
| Cost of Revenue | 238.27 | 283.24 | 241.46 | 203.56 | 118.34 | 93.42 | Upgrade
|
| Gross Profit | 169.5 | 181.59 | 177.99 | 124.9 | 88.35 | 78.93 | Upgrade
|
| Selling, General & Admin | 108.5 | 106.97 | 99.4 | 65.31 | 45.08 | 33.16 | Upgrade
|
| Research & Development | 13.13 | 16.84 | 14.89 | 6.86 | 5.51 | 3.87 | Upgrade
|
| Other Operating Expenses | 15.32 | 17 | 10.7 | 14 | 0.32 | 4.97 | Upgrade
|
| Operating Expenses | 136.95 | 140.82 | 125 | 86.17 | 50.92 | 41.99 | Upgrade
|
| Operating Income | 32.55 | 40.77 | 52.99 | 38.73 | 37.44 | 36.94 | Upgrade
|
| Interest Expense | -26.84 | -24.12 | -21.23 | -14.95 | -18.92 | -19.4 | Upgrade
|
| Earnings From Equity Investments | 0.3 | 4.05 | 1.2 | 1.14 | 1 | 2.48 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.97 | 3.42 | -9.52 | -12.49 | -13.38 | -20.62 | Upgrade
|
| Other Non Operating Income (Expenses) | -11.34 | -14.08 | -4.33 | 1.64 | 4.45 | 7.32 | Upgrade
|
| EBT Excluding Unusual Items | -4.35 | 10.04 | 19.11 | 14.06 | 10.58 | 6.71 | Upgrade
|
| Asset Writedown | - | - | - | - | -0.05 | -0.27 | Upgrade
|
| Pretax Income | -4.35 | 10.04 | 19.11 | 14.06 | 10.53 | 6.44 | Upgrade
|
| Income Tax Expense | -6.45 | 3.78 | -1.07 | 17.97 | 14.35 | 2.21 | Upgrade
|
| Earnings From Continuing Operations | 2.1 | 6.26 | 20.17 | -3.91 | -3.82 | 4.24 | Upgrade
|
| Minority Interest in Earnings | -0.64 | -3.01 | -1.39 | -3.29 | -3.05 | -0.88 | Upgrade
|
| Net Income | 1.46 | 3.24 | 18.78 | -7.2 | -6.87 | 3.36 | Upgrade
|
| Net Income to Common | 1.46 | 3.24 | 18.78 | -7.2 | -6.87 | 3.36 | Upgrade
|
| Net Income Growth | -93.36% | -82.73% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 63 | 63 | 62 | 42 | 39 | 36 | Upgrade
|
| Shares Outstanding (Diluted) | 64 | 63 | 63 | 42 | 39 | 36 | Upgrade
|
| Shares Change (YoY) | -0.31% | 0.47% | 49.37% | 7.86% | 7.69% | 19.48% | Upgrade
|
| EPS (Basic) | 0.02 | 0.05 | 0.30 | -0.17 | -0.18 | 0.09 | Upgrade
|
| EPS (Diluted) | 0.02 | 0.05 | 0.30 | -0.17 | -0.18 | 0.09 | Upgrade
|
| EPS Growth | -93.32% | -82.81% | - | - | - | - | Upgrade
|
| Free Cash Flow | - | 31.93 | -8.77 | -20.97 | -9.01 | 7.67 | Upgrade
|
| Free Cash Flow Per Share | - | 0.50 | -0.14 | -0.50 | -0.23 | 0.21 | Upgrade
|
| Gross Margin | 41.57% | 39.07% | 42.43% | 38.03% | 42.75% | 45.80% | Upgrade
|
| Operating Margin | 7.98% | 8.77% | 12.63% | 11.79% | 18.11% | 21.43% | Upgrade
|
| Profit Margin | 0.36% | 0.70% | 4.48% | -2.19% | -3.32% | 1.95% | Upgrade
|
| Free Cash Flow Margin | - | 6.87% | -2.09% | -6.39% | -4.36% | 4.45% | Upgrade
|
| EBITDA | 50.77 | 57.98 | 68.23 | 46.66 | 42.48 | 40.7 | Upgrade
|
| EBITDA Margin | 12.45% | 12.47% | 16.27% | 14.20% | 20.55% | 23.61% | Upgrade
|
| D&A For EBITDA | 18.22 | 17.21 | 15.24 | 7.93 | 5.04 | 3.76 | Upgrade
|
| EBIT | 32.55 | 40.77 | 52.99 | 38.73 | 37.44 | 36.94 | Upgrade
|
| EBIT Margin | 7.98% | 8.77% | 12.63% | 11.79% | 18.11% | 21.43% | Upgrade
|
| Effective Tax Rate | - | 37.65% | - | 127.79% | 136.28% | 34.25% | Upgrade
|
| Revenue as Reported | - | - | - | - | 209.53 | 173.09 | Upgrade
|
| Advertising Expenses | - | 5.01 | 5.67 | 4.84 | 2.52 | 1.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.